The efficacy of electroacupuncture for the treatment of simple female stress urinary XXXX - comparison with pelvic floor muscle training: study protocol for a multicenter randomized controlled trial.

@entity1 @entity322 @entity158
BACKGROUND: Previous research has shown that electroacupuncture therapy has a potential therapeutic effect for simple female stress urinary @entity322 . In this study, pelvic floor muscle training, the first-line treatment for stress urinary @entity322 in @entity1 based on meta-analysis of numerous randomized control trials and recommended by international clinical practice, is used as a control group to demonstrate whether electroacupuncture therapy is a better method for female stress urinary @entity322 . METHODS/DESIGN: A randomized controlled trial has been designed to evaluate the therapeutic benefit of electroacupuncture for female stress urinary @entity322 compared with pelvic floor muscle training. The safety of electroacupuncture and @entity1 compliance will also be evaluated. Untoward reaction to the electroacupuncture, including a broken needle, fainting on acupuncture, or @entity158 during acupuncture, will be recorded and the therapy will be stopped if an untoward reaction occurs. After we have received full ethical approval and @entity1 consent, @entity1 will be randomized to receive a series of 24 electroacupuncture or pelvic floor muscle training interventions. The frequency and amount of leakage will be measured as the primary outcome parameters. Secondary outcome parameters include the 1-hour pad test, the short-form of the International Consultation on Incontinence Questionnaire, @entity1 subjective effectiveness evaluation, weekly usage of pad, and usage of specialty therapy for female stress urinary @entity322 . DISCUSSION: This trial will help to determine whether electroacupuncture is a more effective treatment than pelvic floor muscle training for @entity1 with female stress urinary @entity322 . TRIAL REGISTRATION: ClinicalTrials.gov NCT01940432 (12 September 2013).
